REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medipharm A.S. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Medipharm A.S. Profile Updated: October 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medipharm A.S. is an enterprise in Slovakia, with the main office in Lipany. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on June 04, 2011. There are currently 25 - 49 (2023) people employed by Medipharm A.S.. From the latest financial highlights, Medipharm A.S. reported a net sales revenue increase of 15.88% in 2023. A negative growth of 6.75% was recorded in its total assets.

Headquarters
Kpt. Nalepku, 637/2
Lipany; Presovsky; Postal Code: 08271

Contact Details: Purchase the Medipharm A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Medipharm A.S. report to view the information.
Outstanding Shares:
Purchase the Medipharm A.S. report to view the information.
Registered Capital:
Purchase the Medipharm A.S. report to view the information.
Incorporation Date:
June 04, 2011
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medipharm A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.88%▲
Total operating revenue
25.76%▲
Operating profit (EBIT)
N/A
EBITDA
603.82%▲
Net Profit (Loss) for the Period
N/A
Total assets
-6.75%▼
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-56.67%▼
Debt to Equity Ratio
N/A
Quick Ratio
0.18%▲
Cash Ratio
0.14%▲

Similar companies

Galvex, Spol. S R.O.
 
Farmacia Martin A.S.
Johnson & Johnson, S.R.O.
 
Hbm Pharma S.R.O.
Hameln Rds S. R. O.
 
Unimed Pharma, Spol. S R.O.
Pharmagal - Bio, Spol. S R.O.
 
Panacea, S.R.O.
Institute Europharm, S.R.O.
 
Vitalos S. R. O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo